In our study, we provided an evidence that the VDR signaling in podocytes has potent renoprotective activities against diabetic nephropathy, and the podocyte VDR at least in part mediates the antifibrotic action of 1,25(OH)2D3 and its analogs. Here, VDR is linked to diabetic kidney disease.